LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) Shareholders’ equity 2016–2025
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.0BFY2025 · since FY2016: $341.3M → $1.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.0B | +22.5% |
| FY2024 | $830.4M | +18.5% |
| FY2023 | $700.9M | +17.3% |
| FY2022 | $597.5M | -27.2% |
| FY2021 | $821.2M | +15.7% |
| FY2020 | $709.5M | -7.5% |
| FY2019 | $767.2M | +36.8% |
| FY2018 | $560.9M | +40.3% |
| FY2017 | $399.8M | +17.1% |
| FY2016 | $341.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice